drugset / Trial / NCT03941548
Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the efficacy and tolerability of once-daily versus twice-daily dosing of CTP-543, in adult patients with chronic, moderate to severe alopecia areata.
Timeline
- Start
- 2019-05-24
- Primary completion
- 2020-04-10
- Completion
- 2020-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTP-543 | Unknown | 12 mg | — |
| Subject | CTP-543 | Unknown | 24 mg | — |